AZD9291, an Irreversible EGFR-TKI, in Relapsed EGFR-mutated Non-small Cell Lung Cancer Patients Previously Treated With an EGFR-TKI, Coupled to Extensive Translational Studies

Herlev Hospital, Copenhagen

Oulu University Hospital, Oulu

National Cancer Institute, Vilnius

Karolinska University Hospital, Stockholm

Drammen Hospital - Vestre Viken HF, Drammen

Norwegian Radium Hospital, Oslo

St Olavs hospital, Trondheim